Heterogeneity between subgroups of first-line chemoimmunotherapy for extensive-stage small cell lung cancer patients: a meta-analysis and systematic review

MLA

Wenwen Kang, et al. “Heterogeneity between Subgroups of First-Line Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer Patients: A Meta-Analysis and Systematic Review.” Frontiers in Oncology, vol. 14, Oct. 2024. EBSCOhost, https://doi.org/10.3389/fonc.2024.1334957.

APA

Wenwen Kang, Jing Cheng, Luyun Pan, Ping Zhan, Hongbing Liu, Tangfeng Lv, Hedong Han, & Yong Song. (2024). Heterogeneity between subgroups of first-line chemoimmunotherapy for extensive-stage small cell lung cancer patients: a meta-analysis and systematic review. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1334957

Chicago

Wenwen Kang, Jing Cheng, Luyun Pan, Ping Zhan, Hongbing Liu, Tangfeng Lv, Hedong Han, and Yong Song. 2024. “Heterogeneity between Subgroups of First-Line Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer Patients: A Meta-Analysis and Systematic Review.” Frontiers in Oncology 14 (October). doi:10.3389/fonc.2024.1334957.